companydata.dkcompanydata.dk

Oscine Therapeutics IVS: Financial statements 2018

CVR: 38663062

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Oscine Therapeutics IVS (CVR 38663062) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,415 and a net result of DKK -1,415. Equity in the 2018 report amounted to DKK 5,585. The solvency ratio was 77.5%.

Gross Profit
DKK -1,415
Profit/Loss
DKK -1,415
Equity
DKK 5,585
Total Assets
DKK 7,208
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Oscine Therapeutics IVS publishes interim reportJun 11, 2018

Oscine Therapeutics IVS has published its interim report for the period May 24, 2017 to December 31, 2017.

Steven Alan Goldman joins Oscine Therapeutics IVS as chairmanMar 22, 2018

As of March 22, 2018, Steven Alan Goldman is registered as chairman of Oscine Therapeutics IVS.

Christina Trojel-Hansen joins Oscine Therapeutics IVS as directorMar 22, 2018

As of March 22, 2018, Christina Trojel-Hansen is registered as director of Oscine Therapeutics IVS.

Steven Alan Goldman steps down as director of Oscine Therapeutics IVSMar 22, 2018

As of March 22, 2018, Steven Alan Goldman has stepped down as director of Oscine Therapeutics IVS.

About Oscine Therapeutics IVS

Oscine Therapeutics IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2017. The company has been dissolved on 15 January 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. According to the 2018 annual report, the company had an average of 0 employees. In 2018, the company reported a gross profit of DKK -1,415 and a net result of DKK -1,415. Equity in the 2018 report amounted to DKK 5,585.

Source: annual report 2018, Danish Business Authority